B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients

BackgroundVaccination is considered as most efficient strategy in controlling SARS-CoV-2 pandemic spread. Nevertheless, patients with autoimmune inflammatory rheumatic diseases receiving rituximab (RTX) are at increased risk to fail humoral and cellular responses upon vaccination. The ability to pre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ana-Luisa Stefanski, Hector Rincon-Arevalo, Eva Schrezenmeier, Kirsten Karberg, Franziska Szelinski, Jacob Ritter, Yidan Chen, Bernd Jahrsdörfer, Carolin Ludwig, Hubert Schrezenmeier, Andreia C. Lino, Thomas Dörner
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2022-04-01
Colecção:Frontiers in Immunology
Assuntos:
RTX (rituximab)
B-cells
vaccination
SARS – CoV – 2
prediction
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fimmu.2022.822885/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.822885/full

Registos relacionados